The −KTS splice variant of WT1 is essential for ovarian determination in mice

Elodie P. Gregoire, Marie Cécile De Cian, Roberta Migale, Aitana Perea-Gomez, Sébastien Schaub, Natividad Bellido-Carreras, Isabelle Stévant, Chloé Mayère, Yasmine Neirijnck, Agnès Loubat, Paul Rivaud, Miriam Llorian Sopena, Simon Lachambre, Margot M. Linssen, Peter Hohenstein, Robin Lovell-Badge, Serge Nef, Frédéric Chalmel, Andreas Schedl, Marie Christine Chaboissier

Research output: Contribution to journalArticlepeer-review

9 Scopus citations

Abstract

Sex determination in mammals depends on the differentiation of the supporting lineage of the gonads into Sertoli or pregranulosa cells that govern testis and ovary development, respectively. Although the Y-linked testis-determining gene Sry has been identified, the ovarian-determining factor remains unknown. In this study, we identified −KTS, a major, alternatively spliced isoform of the Wilms tumor suppressor WT1, as a key determinant of female sex determination. Loss of −KTS variants blocked gonadal differentiation in mice, whereas increased expression, as found in Frasier syndrome, induced precocious differentiation of ovaries independently of their genetic sex. In XY embryos, this antagonized Sry expression, resulting in male-to-female sex reversal. Our results identify −KTS as an ovarian-determining factor and demonstrate that its time of activation is critical in gonadal sex differentiation.

Original languageEnglish
Pages (from-to)600-605
Number of pages6
JournalScience
Volume382
Issue number6670
DOIs
StatePublished - 3 Nov 2023
Externally publishedYes

Bibliographical note

Publisher Copyright:
© 2023 American Association for the Advancement of Science. All rights reserved.

Funding

This research was supported by Agence Nationale de la Recherche grant ANR-19-CE14-0022 SexDiff (M.-C.C.), Fondation Maladies Rares grant FONDATION-GenOmics 2018-1 181003 RNAseq (M.-C.C.), Agence Nationale de la Recherche grant ANR-20-CE14-0022 Ardigerm (M.-C.C.), and Swiss National Science Foundation grants 31003A_173070 (S.N.) and 310030_200316 (S.N.). The Francis Crick Institute receives its core funding from Cancer Research UK (FC001107), the UK Medical Research Council (FC001107), Wellcome (FC001107), and the UK Medical Research Council (U117512772) (R.M., M.L.S., and R.L.-B.).

FundersFunder number
Wellcome TrustU117512772
Fondation Maladies RaresFONDATION-GenOmics 2018-1 181003, ANR-20-CE14-0022
Medical Research Council
Cancer Research UKFC001107
Agence Nationale de la RechercheANR-19-CE14-0022
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung310030_200316, 31003A_173070

    Fingerprint

    Dive into the research topics of 'The −KTS splice variant of WT1 is essential for ovarian determination in mice'. Together they form a unique fingerprint.

    Cite this